Previous Article | Next Article ![]()
Journal of Bacteriology, July 2002, p. 3774-3784, Vol. 184, No. 14
0021-9193/02/$04.00+0 DOI: 10.1128/JB.184.14.3774-3784.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Molecular Genetics and Biotechnology, The Hebrew University-Hadassah Medical School, 91120 Jerusalem, Israel,1 Department of Microbiology, University of Illinois, Urbana, Illinois 618012
Received 11 April 2002/ Accepted 16 April 2002
|
|
|---|
|
|
|---|
The hemA gene of serovar Typhimurium is the first gene in the operon hemA-prfA-dorf1. prfA encodes release factor 1, whereas the function of dorf1 (downstream open reading frame [ORF] 1) is unknown (5, 6). In Escherichia coli, an ORF designated HemK that shows 77% identity to Dorf1 was suggested initially to belong to the heme biosynthesis pathway (27). Recently, it was shown that the E. coli hemK gene encodes a methyltransferase that modifies peptide release factors and affects translation termination (14, 25). The activity of the HemA protein is regulated mainly at the level of protein stability in response to heme levels. HemA protein is more stable in heme-limited cells and is unstable in cells growing under normal conditions (38, 39). The proteolysis of HemA depends on Lon and ClpAP proteases, and the turnover is blocked in strains carrying mutations in both lon and clpP (38).
Heme synthesis is closely linked to iron metabolism. The final step of heme biosynthesis, which is catalyzed by hemH gene product, involves the insertion of ferrous iron (Fe2+) into protoporphyrin IX. The accumulation of porphyrins or iron is toxic to cells. Both porphyrins and iron stimulate the generation of highly reactive oxygen species, leading to damage of most biomolecules (26, 33). Thus, it may be useful for organisms to coordinate the cellular levels of iron and the biosynthesis of heme. The intimate relationship between iron and heme is highlighted by a syndrome displayed by patients with X-linked sideroblastic anemia. These patients display both heme deficiency and the accumulation of intracellular iron (reviewed in reference 8).
Being an essential element, iron has been the subject of many studies. Iron homeostasis is maintained by proteins that regulate iron acquisition, storage, and secretion (reviewed in references 28 and 35). In prokaryotes, Fur (ferric uptake repressor) is a central regulator for the maintenance of cytoplasmic iron levels. Fur associates with Fe2+ to repress transcription of genes involved in iron uptake and to activate expression of genes implicated in the defense against oxygen toxicity (reviewed in references 33 and 35). In low-iron conditions bacterial cells increase the expression of iron transporters and siderophores, whereas in high-iron conditions the expression of proteins involved in defense against oxidative stress is promoted (1, 35). The link between iron metabolism and oxidative stress is further demonstrated by the results that the primary regulators of the oxidative stress response in E. coli, OxyR and SoxRS, induce the synthesis of Fur and that the E. coli fur mutant is hypersensitive to oxidative stress (36, 44).
Although heme synthesis depends upon iron availability and heme products are essential for the defense against oxidative intermediates, very little is known about the coordination of heme synthesis, iron metabolism, and oxidative stress. We screened insertion mutants of S. enterica serovar Typhimurium for sensitivity to hydrogen peroxide and identified the hemA26::Tn10d-Tet mutant. In this mutant, Tn10 was inserted within the promoter region of hemA, leaving the gene intact. In contrast to hemA-null mutants that can hardly grow (40), the low expression of hemA26 by readthrough from the tetR gene made it possible to examine the phenotypes of this mutant. Here we show that exposure of hemA-deficient cells to hydrogen peroxide results in iron-dependent DNA damage and cell death.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids
|
Plasmid construction. To construct pGEM-5'hemA (pSA31), the hemA promoter fragment (838 nucleotides) was amplified from SL1344 chromosomal DNA by PCR by using the primers 452 (5'-CGG GAT CCA TCC TGT CCG GTC TG) and 453 (5'-GCG AAT TCT CCT GAT GCC AGT ACA) and subcloned into unique BamHI and EcoRI sites of pGEM-4 (Promega). To construct Ptac-dorf1-lacI (pSA35), the gene was amplified from SL1344 chromosomal DNA by PCR with the primers 586 (5'-TCC CCC GGG AGC CGC CTT ATC CGA GGA GGA A) and 478 (5'-ACG CGT CGA CGG AGA GCG CAA CAC AGA TA) and subcloned into unique SmaI and SalI sites of Ptac-lacI (pSA10 [31]). In this plasmid, dorf1 is transcribed from the tac promoter under the control of the LacI repressor. The sequence GCAG (five nucleotides upstream of the AUG) was replaced by GGAG to construct a better Shine-Dalgarno for the gene.
RNA isolation and primer extension assays. To isolate total RNA, the cultures were pelleted and resuspended in 10 mM Tris (pH 7.5) and 1 mM EDTA. Lysozyme was added to 0.9 mg/ml, and the samples were subjected to three freeze-thaw cycles. Total RNA was isolated by using Ultraspec RNA according to the manufacturer's protocol (BIOTECX Laboratories), except that 1 ml of reagent was used for 12 to 16 OD600 units of the cells. The RNA samples (30 µg for the chromosomal gene, 3 µg for the plasmid-encoded gene, 2 µg for 5S RNA, and 30 µg for dps and himA) were subjected to primer extension (at 42°C for 45 min) by using AMV-RT (Boehringer) and the indicated end-labeled oligonucleotides: hemA (#655, 5'-GAT CAA GCG TGT CCG GCG), hemH (#531, 5'-TTA CCG CTT CAG GAG T), dps (#315, 5'-AGC AGA TTA GAC GCT TTT G), 5S RNA (#459, 5'-GAG ACC CCA CAC TAC CAT C), and himA (#2309, 5'-AAC AGA TCT TCT GAC ATT TCA GC). The extension products, together with sequencing reactions primed with an end-labeled primer, were separated on a 6% sequencing gel. To estimate the half-life of hemA mRNA, an SL1344 culture grown to mid-exponential phase in LB medium was split into four subcultures, and two of these were treated with 1 mM hydrogen peroxide. After 1 min, rifampin (0.2 mg/ml) was added to one treated and one nontreated culture. At selected time intervals after the rifampin addition, samples were withdrawn from treated and control cultures, and total RNA was extracted and subjected to a primer extension assay.
S1 nuclease assay. The S1 nuclease protection assay was done as previously described (20) except that the annealing mixture (RNA and labeled probe) was treated with 70 U of S1 nuclease (MBI Fermentas) for 2 h. The probe was generated in a PCR machine with one end-labeled primer (#444, 5'-GGC ACC TGT ATC GCT GCG AG) and the hemA promoter fragment (844 nucleotides) as a template. The hemA promoter fragment was amplified from SL1344 chromosomal DNA by PCR with primers 452 and 453 (see plasmid construction). Total RNA (35 µg) and excess of labeled single-stranded DNA probe were mixed in 50 µl of hybridization buffer as described previously (20).
Hydrogen peroxide sensitivity assays. Bacterial cultures grown to an A600 of 0.2 to 0.4 in LB were treated with 2.5 mM hydrogen peroxide. To determine viability, aliquots were taken at the indicated time points, diluted, and plated onto LB or LB-Tet plates. When indicated, the cells were exposed to 1 mM 2,2'-dipyridyl (Sigma) for 15 min or 3 mM potassium cyanide for 5 min prior to treatment with hydrogen peroxide. For ALA supplementation experiments, cells grown to an A600 of 0.2 to 0.4 in NB medium with or without 50 µg of ALA (4)/ml were treated with 1 mM hydrogen peroxide. Viability was assayed as described above.
Hydrogen peroxide degradation assay. Hydrogen peroxide was determined by horseradish peroxidase-catalyzed oxidation of phenol red (22). Cultures grown to an A600 of 0.2 in LB medium were treated with 0.5 and 1 mM hydrogen peroxide for 10 min at 37°C. Then, 1 ml of each sample was pelleted, and 40 to 200 µl of the supernatants were mixed with phosphate-buffered saline (to give a final volume of 1 ml) containing horseradish peroxidase (8.4 purpurogallin units/ml) and phenol red (0.28 mM) and incubated at room temperature for 10 min before the addition of 10 µl of 5 M NaOH. The absorbance of the reaction mixtures was measured at 610 nm and correlated with values obtained by using appropriate dilutions of the reagent.
Respiration assay. The respiration rate of exponentially (A600 = 0.2 to 0.3) growing cells in LB medium was measured by using an oxygen electrode (Rank Bros., Cambridge, United Kingdom).
SNG sensitivity assay. Bacterial cultures of each strain were grown to an A600 of 0.18 in LB medium, and then half were treated with 1 mM 2,2'-dipyridyl (Sigma) for 20 min. Half of the iron chelator-treated cultures and half of the control untreated cultures were then treated with 1 µg of streptonigrin (SNG; Sigma)/ml. To determine viability, aliquots were taken at 0, 10, 20, and 40 min after the addition of SNG, diluted, and plated onto LB or LB-Tet plates.
Analysis of DNA topology. Bacterial strains (SL1344 and SL1344 hemA26::Tn10) carrying pKK177-3 grown to mid-log phase in LB medium were split, and half were treated with 1 mM 2,2'-dipyridyl (Sigma) for 20 min. Thereafter, the treated and the untreated cultures were exposed to 0, 0.5, and 1 mM hydrogen peroxide for 15 min. To detect plasmid DNA strand breaks, the samples were analyzed on 1% agarose gels. The gels were run at 8 V/cm for 4 h in 40 mM Tris-acetate buffer. For documentation, the gels were stained with ethidium bromide (1 µg/ml). To detect changes in the negative supercoiling of the DNA, plasmid samples were analyzed on 1.4% agarose gels containing 10 µg of chloroquine/ml as described in Weinstein-Fischer et al. (41). The gels were run at 2.5 V/cm in 50 mM Tris phosphate buffer (pH 7.2) containing 10 µg of chloroquine/ml for 19 h with recirculated buffer. For documentation, the gels were soaked for 2 h in water and then stained with ethidium bromide (1 µg/ml) for 1 h.
Measurement of intracellular free iron.
Intracellular iron that is not incorporated in proteins was measured by whole-cell electron paramagnetic resonance (EPR) spectroscopy (19). Cultures were grown aerobically for at least five generations in 1 liter of LB medium to an A600 of 0.2 to 0.3. Cells were centrifuged and resuspended in 9 ml of LB. Then, 1 ml of 0.2 M desferrioxamine was added, and cells were incubated for 15 min at 37°C with shaking. The cells were then centrifuged, washed with 5 ml of cold 20 mM Tris buffer (pH 7.4), and resuspended in 400 µl of cold 20 mM Tris (pH 7.4)-10% glycerol. Then, 200 µl of the suspended cells was loaded into an EPR tube, frozen in dry ice, and stored at -80°C until analysis. Ferric sulfate standards were prepared in the same Tris-glycerol solution; the exact iron concentration was calculated by using a
mM value of 2.865 cm-1 at 420 nm. The EPR signals were averaged from 30 scans by using a Varian Century E-112 X-band spectrophotometer equipped with a Varian TE102 cavity and temperature controller. The spectrometer settings were as follows: field center, 1,570 G; receiver gain, 3,200; field sweep, 400 G; modulation amplitude, 12.5 G; temperature, -125°C; and power, 30 mW. The measured EPR signals were converted to approximate intracellular concentrations by normalization to the cell density by using the relation that 1 ml of a culture of LB medium-grown E. coli at an A600 of 1 comprises 0.47 µl of intracellular volume (16).
|
|
|---|
![]() View larger version (41K): [in a new window] |
FIG. 1. Mapping of the hemA promoter and the insertion mutant. (A) Primer extension analysis of chromosomal (30 µg, total RNA) and plasmid-encoded (3 µg, total RNA) hemA promoter region. Total RNA was extracted from exponential-phase (A600 = 0.3) SL1344 and SL1344 cells carrying the plasmid encoding the hemA promoter region (pGEM-5'hemA). The sequencing reaction was carried out with the same primer. (B) Sequence of the hemA promoter region. The horizontal arrows indicate the start sites observed by primer extension. Brackets indicate the -10 regions of P1 and P2. The bases matching the -10 hexamers of the 70 consensus are underlined. Both P1 and P2 promoters have no obvious -35 sequence. The vertical arrow indicates the site of insertion of the transposon Tn10d. (C) S1 mapping of the hemA transcripts. Total RNA was extracted from exponential cultures (A600 = 0.3) of SL1344 wild type and SL1344 hemA26 mutant prior to and after exposure to 1 mM hydrogen peroxide (15 min). To analyze hemA transcription from the tetR promoter, hemA26 strain was exposed to 10 µg of tetracycline/ml for 15 min. S1 mapping was carried out with an end-labeled single-stranded DNA fragment (612 bases) complementary to hemA. The fragments protected by hemA mRNA in wild-type and hemA26 cells were 93 (indicated as "+1") and 119 (indicated as "+26") nucleotides long, respectively. +1, Transcription start site of P1; +26, insertion site (i.e., the position at which transcription originating at the tetR promoter enters into hemA).
|
|
View this table: [in a new window] |
TABLE 2. ALA and tetracycline complementation of SL1344 wild-type and hemA26 mutant strains
|
The hemA gene is the first gene in the operon hemA-prfA-dorf1. The gene prfA, encoding release factor 1, is essential, and mutations in this gene lead to impaired cell division and sometimes to cell lysis due to inhibition of septation (29). The function of dorf1 is unknown (5, 6). In E. coli, an ORF designated HemK that shows 77% identity to Dorf1 was recently shown to encode a methyltransferase that modifies peptide release factors and affects translation termination (14, 25). Because transcription of the operon in hemA26 strain is impaired, we examined whether plasmids expressing the genes prfA and dorf1 could complement the growth defects of this mutant. To test the effect of prfA, the hemA26 cells were transformed with a plasmid expressing the E. coli prfA gene, which was previously used to complement a null mutant of prfA of S. enterica serovar Typhimurium (7). To examine dorf1, the gene was cloned downstream of the tac promoter under the control of the LacI repressor. We found that plasmids expressing prfA or dorf1 had no effect on the doubling time of hemA26 (Table 2). In addition, ALA supplements improved the growth of these strains exactly as it did that of their hemA26 parent (Table 2). We conclude that the growth deficiency of the hemA mutant is primarily the result of inadequate heme biosynthesis.
S. enterica serovar Typhimurium hemA26 is highly sensitive to hydrogen peroxide. To quantify the sensitivity of the hemA26 mutant to hydrogen peroxide, we examined the viability of exponential phase cells after exposure to 2.5 mM hydrogen peroxide. The assays demonstrated that only 7% of the hemA26 mutant cells survived the first 15 min of treatment (Fig. 2). In contrast, 60% of wild-type cells survived. We also examined hydrogen peroxide sensitivity of hemA26 cells carrying prfA or dorf1 plasmids. We found that, although the prfA plasmid increased the total number of CFU (three- to fourfold), both hemA26/pprfA and hemA26/pdorf1 cells were as sensitive to hydrogen peroxide as were hemA26 cells in the absence of the plasmids (not shown).
![]() View larger version (15K): [in a new window] |
FIG. 2. Hydrogen peroxide killing assay. Bacterial cultures (SL1344 wild-type, SL1344 katG katE, and SL1344 hemA26 strains) grown to A600 = 0.2 to 0.4 in LB medium were treated with 2.5 mM hydrogen peroxide. Viability was assayed at the indicated time points by plating the cells on LB or LB-Tet plates.
|
![]() View larger version (25K): [in a new window] |
FIG. 3. ALA supplementation in hydrogen peroxide killing. Bacterial cultures (i.e., SL1344 wild type [A], SL1344 hemA26 mutant [B], SL1344 hemA26 mutant carrying pTE367 [prfA] [C], and SL1344 hemA26 mutant carrying pSA35 [Ptac-dorf1 lacI] [D]) grown to A600 = 0.2 to 0.4 in NB in the absence or in the presence of ALA (at 50 µg/ml) were treated with 1 mM hydrogen peroxide. Viability was assayed at the indicated time points by plating the cells on LB or LB-Tet plates. To induce expression of dorf1 from the Ptac-dorf1 plasmid, the cells were dilute in NB medium supplemented with IPTG (isopropyl-ß-D-thiogalactopyranoside; 0.1 µg/ml).
|
|
View this table: [in a new window] |
TABLE 3. Remaining hydrogen peroxide
|
The hemA26 mutant is prone to iron-mediated DNA damage. The result that the hemA26 mutant was more sensitive to hydrogen peroxide than were mutants of catalases led us to suspect that inactivation of heme synthesis might affect iron homeostasis. In higher organisms interruptions in heme synthesis can trigger massive import of iron into the cell, presumably because the lack of heme is interpreted by regulatory controls as an indication of iron deficiency (8). SNG has been previously used to assess free iron levels in bacterial cells (43). SNG is an aminoquinone that is cyclically reduced and oxidized inside bacteria, producing superoxide and hydroxyl radicals (10, 13). It has been found that the antibiotic activity of SNG is enhanced by iron and that an increase in the levels of cellular free ferrous iron leads to the production of higher levels of reactive oxygen species and to more damage (42). We used SNG to assess iron-mediated DNA damage in the hemA26 mutant. Exposure of the hemA26 mutant to a low concentration of SNG (1 µg/ml) was sufficient to kill 90% of the cells within the first 10 min (Fig. 4A). Both wild-type cells and the katG katE double mutant were much less susceptible, with only 20 to 30% of the cells killed. 2,2'-Dipyridyl is an iron chelator that penetrates cells and chelates intracellular ferrous iron as well as iron outside the cells. The addition of 2,2'-dipyridyl rendered the hemA26 strain tolerant to SNG, indicating that the effects of SNG observed with the hemA26 mutant were related to free ferrous iron (Fig. 4A). Similarly, both 2,2'-dipyridyl and desferrioxamine, a cell-permeable iron chelator that is structurally unrelated to dipyridyl, fully protected the mutant against 2.5 mM hydrogen peroxide (Fig. 4B and data not shown).
![]() View larger version (20K): [in a new window] |
FIG. 4. Effect of iron chelator. (A) SNG survival assay. Bacterial cultures of each strain carrying the prfA plasmid were grown to an A600 of 0.18 in LB medium, and then half were treated with 1 mM 2,2'-dipyridyl (dpy) for 20 min. Thereafter, the iron chelator-treated cultures and the control untreated cultures were treated with 1 µg of SNG/ml. Viability was assayed at 0, 10, 20, and 40 min after the addition of SNG by plating the bacterial cells onto LB or LB-Tet plates. The average of five independent experiments is shown. (B) Hydrogen peroxide killing. Wild-type and hemA26 strains carrying the prfA plasmid were examined for hydrogen peroxide sensitivity (2.5 mM) with or without prior treatment with 1 mM 2,2'-dipyridyl for 15 min. In both experiments, the cells were introduced with the prfA plasmid (pTE367) to adjust the total number of hemA26 CFU.
|
![]() View larger version (42K): [in a new window] |
FIG. 5. Analysis of plasmid DNA topology. (A) Detection of single-strand breaks. Cultures of wild-type SL1344 and hemA26 mutant carrying pKK177-3 were grown to an A600 of 0.25 in LB mutant and were then exposed to 0, 0.5, and 1 mM hydrogen peroxide for 15 min. Where indicated, the iron chelator 2,2'-dipyridyl (1 mM) was added to the cells 15 min prior to the treatment with hydrogen peroxide. Plasmid DNA samples were separated on a 1% agarose gel. DNA was visualized by ethidium bromide staining. uncut, pKK177-3 DNA; cut, pKK177-3 DNA digested with EcoRI. (B) Detection of changes in the negative supercoiling of the DNA. The plasmid samples from above were analyzed on 1.4% agarose gels containing 10 µg of chloroquine/ml. At this chloroquine concentration, the most relaxed molecules migrate most rapidly through the gel (41). DNA was visualized by ethidium bromide staining.
|
![]() View larger version (17K): [in a new window] |
FIG. 6. EPR analysis of intracellular free iron. Samples for EPR analysis were taken from exponential-phase cultures of SL1344 wild-type, hemA26, and fur-1 strains. The iron concentration was calculated based on the following ferric sulfate standards: wild type, 36 µM intracellular chelatable iron; hemA26, 45 µM iron; fur-1, 190 µM iron.
|
![]() View larger version (27K): [in a new window] |
FIG. 7. Respiratory blocks sensitize Salmonella to killing by hydrogen peroxide. (A) Oxygen consumption was measured in exponential phase cultures grown in LB medium. Tetracycline (10 µg/ml), or ALA (50 µg/ml) were added where indicated. (B) Killing by hydrogen peroxide in respiration deficient cells. Where indicated, 3 mM potassium cyanide was added to cells 5 min before challenge with 2.5 mM hydrogen peroxide. Viability was assayed at the indicated time points. The addition of cyanide alone did not diminish cell viability.
|
![]() View larger version (46K): [in a new window] |
FIG. 9. Primer extension assays. (A) Cultures at exponential phase were exposed to 0, 0.2, and 1 mM of hydrogen peroxide for 5 min. (B) The cultures shown in panel A were exposed to the iron chelator (1 mM) for 15 min prior to the treatment with hydrogen peroxide. (C) Cultures of wild-type and hemA26 strains grown to an A600 of 0.25 in LB medium were split. One part of each culture was treated with the iron chelator 2,2'-dipyridyl (1 mM) for 15 min. Thereafter, the dipyridyl treated and the untreated cultures were exposed to 1 mM hydrogen peroxide for 5 min. In addition, two parts of hemA26 culture were exposed to 10 µg of tetracycline/ml for 10 min, and then one was further exposed to hydrogen peroxide (1 mM) for 5 min.
|
![]() View larger version (39K): [in a new window] |
FIG. 8. Primer extension assays. (A) Cultures of SL1344 wild-type, oxyR, and fur1 strains were grown to an A600 of 0.3 to 0.4 in LB medium, and then half of each culture was treated with 1 mM hydrogen peroxide for 15 min. P1 of hemA mutant is shown. No expression could be detected from P2. (B) A wild-type culture was split into four subcultures, and two were treated with 1 mM hydrogen peroxide. Rifampin (0.2 mg/ml) was added after 1 min to one treated and one untreated culture. Samples were taken from control untreated and treated cultures 1, 3, 6, 11, and 16 min after the addition of hydrogen peroxide. Approximately 80% of the hemA mRNA in the cells exposed to hydrogen peroxide and 95% of the nonexposed mRNA were degraded within the first 2 min of rifampin treatment, as measured with a BioImaging Analyzer.
|
The activation of hemH transcription by hydrogen peroxide was oxyR dependent (Fig. 9A). A recent study has documented such an induction for the E. coli hemH gene (45). Interestingly, activation of hemH by oxidative stress in the hemA26 mutant was greatly reduced, particularly at millimolar concentrations of hydrogen peroxide. Likewise, hemH induction in fur mutant cells was reduced. The addition of 2,2'-dipyridyl to both hemA26 and fur strains restored regulation, resulting in activation of hemH in response to the treatment (Fig. 9B). Similarly, the addition of tetracycline to restore hemA transcription and thereby heme synthesis also restored hemH activation by hydrogen peroxide (Fig. 9C). These results suggested that conditions that accelerate oxidative DNA damage simultaneously suppress the hydrogen peroxide dependent transcription activation of hemH.
To find out whether hemA26 and fur mutations only reduce the expression of genes in the heme pathway, we analyzed the transcription of dps, which encodes a nonspecific DNA-binding protein that is known to be induced by OxyR in response to hydrogen peroxide (reviewed in reference 33). We noticed that hydrogen peroxide- dependent activation of dps in hemA26 or fur mutant strains was reduced and that the removal of iron restored efficient induction of dps (Fig. 9A and B). In contrast, analysis of mRNA levels of himA encoding the
subunit of IHF protein in hemA26 and fur mutants showed that hydrogen peroxide did not suppress its expression, indicating that this reduction in expression by hydrogen peroxide is specific to oxyR-regulated genes.
|
|
|---|
While the reduced scavenging activity is an obvious consequence of diminished catalase activity, the connection between poor respiration and accelerated DNA damage is less obvious. The present study shows that exposure of a heme-deficient mutant with reduced respiration to hydrogen peroxide results in extensive iron-mediated DNA damage and cell death. The inactivation of heme synthesis does not change the amount of intracellular iron, and we propose that it is the respiratory deficiency that causes the accumulation of NADH, which ultimately provides to free iron the electrons that drive the Fenton reaction. Previous work demonstrated that inhibition of any step in the respiratory chain dramatically accelerates the rate at which hydrogen peroxide kills E. coli (17, 32). It was proposed that, by blocking the oxidation of NADH, respiratory inhibitors would increase the amount of cytosolic reductants available to reduce free ferric iron. In the presence of hydrogen peroxide, the ferrous iron thus formed will donate an electron and generate a hydroxyl radical that can damage DNA. Although NADH can directly reduce free iron at a low rate, recent data indicate that it does so in vivo much more efficiently through the agency of an NADH:flavin oxidoreductase (A. N. Woodmansee and J. Imlay, unpublished data). Reduced flavins are the direct electron donors.
Interestingly, control of heme biosynthesis is attuned more to oxidative stress than to iron levels. We found that neither iron loading nor iron depletion had a significant effect on hemA or hemH expression in S. enterica serovar Typhimurium. Mutations in fur appeared not to affect transcription. This result contrasts with the example of Bradyrhizobium japonicum, in which iron-dependent regulation of heme biosynthesis involves both Fur and a Fur-like protein Irr: Fur regulates hemA and Irr regulates hemB in response to iron (11, 12). Since free-iron levels are unaffected by the hemA26 allele, we infer that deficiencies in heme biosynthesis are not compensated for by accelerated iron loading of the cell. Thus, iron metabolism and heme biosynthesis seem not to be coordinated in Salmonella.
However, heme biosynthesis is affected on multiple levels by oxidative stress. Low levels of hydrogen peroxide activate OxyR and induce hemH, which encodes the ultimate enzyme in heme biosynthesis. Yet the transcription of hemA, which encodes the initial pathway enzyme, is reduced. This arrangement is unusual and warrants some speculation. Induction of heme synthesis during oxidative stress seems reasonable because OxyR also induces the synthesis of a major heme-requiring enzyme, hydroperoxidase I. Nevertheless, the reduction in hemA mRNA levels while the hemH mutant is activated suggests that during oxidative stress it may be important to simultaneously shut off the heme synthesis pathway at its first step, while completing the conversion of potentially toxic intermediate products into heme. Furthermore, the induction of hemH-encoded ferrochetalase may be particularly useful in allowing the heme biosynthetic pathway to scavenge intracellular iron before it is oxidized by hydrogen peroxide.
We have shown that higher (millimolar) concentrations of hydrogen peroxide affect the ability of OxyR to induce expression of the its target genes. This effect was exacerbated by high levels of free iron (in the fur mutant) or the inhibition of respiration (in the hemA26 mutant), conditions which accelerate Fenton chemistry. Whether the accelerated Fenton reaction renders the OxyR protein inactive or we observed a general effect on protein synthesis and/or degradation is not clear. It is interesting that the mRNA levels of the two non-oxyR-regulated genes we tested (himA of IHF and Z2519) seem to remain unchanged, except for in the fur mutant (Fig. 9A and data not shown). Further study will be needed to clarify transcriptional responses to the rate of Fenton chemistry.
This study was supported by The Bruno Goldberg Endowment Fund; by the Zetner Family Fund for Research in Cancer, Heart Disease, and Pharmaceutical Chemistry; and by The Israel Science Foundation, founded by The Academy of Sciences and Humanities-Centers of Excellence Program (S.A.). This work was also supported by grant GM59030 from the National Institutes of Health to J.I.
|
|
|---|
S). Mol. Microbiol. 39:1533-1545.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»